Monday 28 May 2018

Fire Alarm and Detection Market size is Projected to reach USD 23. 2 billion by 2025 : Grand View Research, Inc.


The global fire alarm market size is expected to reach USD 23. 2 billion by 2025, according to a study by Grand View Research, Inc., registering a CAGR of 4.3% during the forecast period. Fire alarm and detectors can protect assets, avoid casualties, and prevent property damages by raising alerts about a fire outbreak at an early stage. Recent accidents, such as the Grenfell Tower fire in London in June 2017, have triggered the need to equip high rise towers with effective fire alarm and detection systems. Growth in new residential and commercial construction activities as well as renovation projects, and subsequent need to upgrade existing fire alarm and detection systems are also emerging as key factors driving fire alarm and detection market growth.
Advances in technology have resulted in introduction of wireless and quick response systems that can detect the exact location of the fire and curb false alarms. These systems are suitable for large-scale applications. However, these systems are expensive as they incorporate several electronic components and devices. Conventional systems are preferred for small-scale applications owing to cost constraints.
Fire safety norms are particularly stringent in North America and Europe. Moreover, the two regions are home to prominent market players, such as Emerson Electric Co., Fike Corporation, Gentex Corporation, and Halma plc. Hence, the North American and European regional markets are currently dominating the fire alarm market. However, regional markets in emerging economies, such as India and China, are expected to exhibit a higher CAGR over the forecast period in line with growing awareness about fire safety.
Full research report on fire alarm market analysis:
https://www.grandviewresearch.com/industry-analysis/fire-alarm-market

Further key findings from the study suggest:
·         Rising adoption of fire alarm & detection systems in response to stringent fire safety norms has propelled the growth of the global market, which is expected to register a CAGR of over 4.0% during the forecast period
·         Addressable systems are expected to emerge as the largest segment, projected to reach a value of USD 17.2 billion by 2025. This is owing to numerous benefits, such as quick response time, high reliability, and reduced cabling, offered by addressable alarm technology
·         Market size of the smoke detectors segment is projected to reach USD 10.4 billion over the forecast period. This can be attributed to the affordability of smoke detectors as well as their capability to detect low-intensity fires
·         The market for alarm & detection systems used in commercial applications is expected to continue dominating the overall market over the forecast period, and the market size of the segment is expected to exhibit a CAGR of over 4.5%
·         North America is currently the largest market and is expected to remain so over the forecast period. The region is known for early adoption of fire detection technology and is also home to leading market players
·         Emersion Electric Co.; Fike Corporation; Gentex Corporation; Halma plc; Hochiki Corporation; and Honeywell International, Inc. are some of the prominent players in the market.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies
Grand View Research has segmented the global fire alarm & detection market based on alarm technology, detection technology, application, and region:
Fire Alarm & Detection Alarm Technology Outlook (Revenue, USD Million, 2014 - 2025)
·         Conventional Systems
·         Addressable Systems
Fire Alarm & Detection Technology Outlook (Revenue, USD Million, 2014 - 2025)
·         Flame Detectors
·         Smoke Detectors
·         Heat Detectors
Fire Alarm & Detection Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Commercial
·         Industrial
·         Residential
Fire Alarm & Detection Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Mexico
o    Canada
·         Europe
o    U.K.
o    Germany
·         Asia Pacific
o    China
o    India
o    Japan
·         South America
o    Brazil
·         MEA
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/

Healthcare Contract Research Organization (CRO) Market is Projected to reach USD 51.3 billion by 2024 : Grand View Research Inc.


The global healthcare contract research organization (CRO) market is expected to reach USD 51.3 billion by 2024, according to a new study by Grand View Research Inc. Increasing drug development cost is expected to drive market demand over the forecast period. With the increasing number of patents expiring, increasing number of partnerships to identify biologics and new compounds and growing R&D costs, drug maker and sponsor companies are under pressure to replace the revenue loss specifically due to generics, which has further made drug development more expensive and complex.
Moreover, owing to the increasing incidence rates of chronic diseases such as cancer, Alzheimer’s and other infectious diseases in children, government funding has increased, which have led to increasing R&D activities. For instance, in January 2015, the U.S. announced an investment of USD 215 million for precision medicine initiative. The investment was broken up for NIH (USD 130 million), NCI (USD 70 million), and FDA (USD 10 million).
In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing of research activities. Even government organizations are outsourcing their clinical trial activities to CROs so that they can carry out the clinical trials with the required infrastructure, expertise, and minimize cost and timelines. In 2015, the Canadian Federal Budget made an investment of USD 1.33 billion for the Canada Foundation for Innovation (CFI).
Full research report on healthcare contract research organization (CRO) market analysis:
https://www.grandviewresearch.com/industry-analysis/healthcare-contract-research-outsourcing-market

Further key findings from the study suggest:
·         Clinical trial services dominated the market in 2016 owing to the fact that it comprises four elaborate phases including human subjects. The increasing complexities in R&D trends have raised the need for expertise, thereby shortening the time required to commercialize the molecule.
·         In January 2016, Charles River Laboratories International, Inc. entered into a definitive agreement to acquire WIL Research for approximately USD 585 million. The acquisition is expected to strengthen Charles’ ability to partner with global clients.
·         The high R&D spending in oncology has also fueled the need for healthcare contract research outsourcing. Realizing this demand, France-based laboratory, XenTech increased its capacity of its animal care to 50% along with increasing collaborative research projects.
·         North America was the largest regional market with revenue share estimated at over 40% owing to the presence of global industries, which invest maximum of their revenue in research activities. In addition, many academic institutes receive grants to undertake these activities. For instance, in July 2015, the University of Toronto received USD 1.5 billion under the Medicine by Design initiative.
·         Europe was the second largest market in 2016. This is attributed to the tax benefits offered to the large and small-scale companies to promote more contract research outsourcing activities. The large companies can claim 30% deducible from the income of their R&D expenditure. In case of small and medium sized enterprises, it is 225% for the R&D expenditure.
·         Asia Pacific is the fastest growing industry due to the reduced cost it offers in comparison to the U.S and other developed economies. Increasing incidence rate of chronic and lifestyle diseases such as heart disease and diabetes coupled with ease in patient recruitment and available expertise for the clinical trials are few drivers propelling growth of the Asian healthcare CRO market.
·         China and India are projected to witness tremendous growth in the contract research outsourcing market owing to their treatment naïve patient pool coupled with disease prevalence rate. Furthermore, genetically diverse population, highly qualified English-speaking investigators, well equipped hospitals are other opportunities offered by India for global clinical trials.
·         In July 2014, Catalent Pharma Solutions opened its oral formulation development lab in Japan. The laboratory, which opened in September, also expanded its CMO manufacturing capacity in the same lab.
·         CROs are in a process of continuously improving their portfolio by integrating services with technology. This enables them to save more on time and deliver efficient and desired results to the clients. In October 2015, PPD joined hand with Oracle to use its cloud technology named Oracle Siebel CTMS.
·         In addition to offering improved services, CROs are in the process of collaborating to promote their services at a global level. For instance, in May 2014, ClinDatrix, Inc. collaborated with six other CRO’s to offer services to multinational clinical trials. The collaboration will strengthen its presence globally apart from the U.S. and Canada.
·         Major contributors are Quintiles, Covance, Pharmaceutical Product Development, LLC (PPD), Parexel, Charles River Laboratories (CRL), ICON plc, inVentiv Health, Medidata Solutions, and Theorem Clinical Research. According to the US database of trials, Parexel, Quintiles and PPD are involved in large number of collaboration with the sponsors pertaining to clinical trials.
·         In April 2015, Pfizer selected PPD as its third most preferred CRO. PPD has assisted Pfizer in extending its global reach that is expected to advance Pfizer’s growing portfolio. Furthermore, in June 2015 Aeterna Zentaris selected Ergomed for phase III study to identify the efficacy of Macrelin, a novel orally active ghrelin agonist to evaluate AGHD.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the global Healthcare Contract Research Organization (CRO) market report on the basis of type, service, and regions:
Type (Revenue, USD Million, 2014 - 2024)
·         Drug Discovery
o    Target validation
o    Lead identification
o    Lead optimization
·         Pre-Clinical
·         Clinical
o    Phase I Trial Services
o    Phase II Trial Services
o    Phase III Trial Services
o    Phase IV Trial Services
Service (Revenue, USD Million, 2014 - 2024)
·         Project Management/Clinical Supply Management
·         Data Management
·         Regulatory/Medical Affairs
·         Medical Writing
·         Clinical Monitoring
·         Quality Management/ Assurance
·         Bio-statistics
·         Investigator Payments
·         Laboratory
·         Patient and site Recruitment
·         Technology
·         Others
Regional Outlook (Revenue, USD Million, 2014 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
o    France
·         Asia Pacific
o    Japan
o    China
o    India
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/


Athletic Footwear Market size is Projected to reach USD 95.14 billion by 2025 : Grand View Research, Inc.


The global athletic footwearmarket size is expected to reach USD 95.14 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.1% during the forecast period. The market is estimated to witness considerable growth over the forecast period owing to growing global population, rising awareness regarding health benefits, and active participation in fitness activities and global sports events.
Major global sports events such as Olympics, ICC Cricket World Cup, National Basketball Association (NBA) league, FIFA World Cup, and The Championships, Wimbledon play an imperative role in fuelling demand for athletic footwear. It has been observed that the market witnessed a higher growth rate during the years when Olympics (both summer and winter) took place, that is during 2012, 2014, and 2016, owing to training and participation of aspiring as well as established athletes and sportspersons.
Athletic footwear is typically made up of three primary components, namely upper section, mid sole, and outsole. Major players, such as Adidas AG; Nike, Inc.; and Under Armour, Inc. are innovating upper section of shoes using the 3D printing technology.
The mid sole plays an important role as it is responsible for ensuring stability and providing cushioning to users. Prominent manufacturers have been focusing on enhancing the mid sole to ensure the comfort of athletes. For instance, Adidas AG adopted the Boost technology over the traditional Ethylene Vinyl Acetate (EVA)-based technology. The Boost technology is based on using capsules of Thermoplastic Polyurethane (TPU), an elastomer possessing high abrasion rate, high flexibility levels, and longer life as compared to conventional EVA.
Full research report on athletic footwear market analysis:
https://www.grandviewresearch.com/industry-analysis/athletic-footwear-market

Further key findings from the report suggest:
·         Running shoes are anticipated to register the highest shipments by 2025 at around 392 million units
·         The sports shoes segment was valued at around USD 18.3 billion in 2017 and is likely to post the highest CAGR during the forecast period
·         The kids segment is poised to exhibit the highest CAGR of 6.3% in terms of revenue during the forecast period
·         The North America region accounted for the largest revenue share in the market in 2017 and is projected to continue its dominance throughout the forecast period
·         The key players in the industry include Nike, Inc.; Adidas AG; Under Armour, Inc.; and Puma SE.
View more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/consumer-goods
Grand View Research has segmented the global athletic footwear market into category, gender, and distribution channel.
Athletic Footwear Category Outlook (Volume, Million Units; Revenue, USD Million, 2014 - 2025)
·         Aerobic Shoes
·         Running Shoes
·         Walking Shoes
·         Trekking & Hiking Shoes
·         Sports Shoes
o    Football
o    Basketball
o    Tennis
o    Rugby & American football
o    Cricket
o    Baseball
o    Ice Hockey
o    Others
Athletic Footwear Gender Outlook (Volume, Million Units; Revenue, USD Million, 2014 - 2025)
·         Men
·         Women
·         Kids
Athletic Footwear Retail Channel Outlook (Volume, Million Units; Revenue, USD Million, 2014 - 2025)
·         Brick & Mortar
·         E-commerce
Athletic Footwear Regional Outlook (Volume, Million Units; Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
·         Asia Pacific
o    Australia
o    China
o    India
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/